Abstract
AbstractMatrix metalloproteinase-9 (MMP-9) is an endopeptidase that remodels the extracellular matrix and has been implicated as a major driver in cancer metastasis. Hence, there is a high demand for MMP-9 inhibitors for therapeutic purposes. For such drug design efforts, large amounts of MMP-9 are required. Yet, the catalytic domain of MMP-9 (MMP-9Cat) is an intrinsically unstable enzyme that tends to auto-cleave within minutes, making it difficult to use in drug design experiments and other biophysical studies. We set our goal to design MMP-9Catvariant that is active but stable to autocleavage. For this purpose, we first identified potential autocleavage sites on MMP-9Catusing mass spectroscopy and then eliminated the autocleavage site by predicting mutations that minimize autocleavage potential without reducing enzyme stability. Four computationally designed MMP-9Catvariants were experimentally constructed and evaluated for auto-cleavage and enzyme activity. Our best variant, Des2, with 2 mutations, was as active as the wild-type enzyme but did not exhibit auto-cleavage after seven days of incubation at 37°C. This MMP-9Catvariant, with an identical to MMP- 9CatWT active site, is an ideal candidate for drug design experiments targeting MMP-9 and enzyme crystallization experiments. The developed strategy for MMP-9CATstabilization could be applied to redesign of other proteases to improve their stability for various biotechnological applications.
Publisher
Cold Spring Harbor Laboratory
Reference44 articles.
1. Cauwe, B. , Steen, P. E. V. Den and Opdenakker, G. (2007, May) The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol., Taylor & Francis.
2. Matrix-metalloproteinase-9 is cleaved and activated by Cathepsin K;BMC Res. Notes, BioMed Central Ltd,2015
3. Tallant, C. , Marrero, A. and Gomis-Rüth, F. X. (2010, January 1) Matrix metalloproteinases: Fold and function of their catalytic domains. Biochim. Biophys. Acta -Mol. Cell Res., Elsevier.
4. Conlon, G. A. and Murray, G. I. (2019, April 1) Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis. J. Pathol., John Wiley and Sons Ltd.
5. Rydlova, M. , Holubec, L. , Ludvikova, M. , Kalfert, D. , Franekova, J. , Povysil, C. and Ludvikova, M. (2008, March 1) Biological activity and clinical implications of the matrix metalloproteinases. Anticancer Res., International Institute of Anticancer Research.